Creo Medical Share Discussion Threads

[someuwin] 22/10/2019 10:42

Creo Medical‏ @CreoMedical · 3 minutes ago

#UEG2019 marks the commercial launch of Speedboat and showcases our wider GI suite for the first time. Visit us at Booth 46 to find out more! …
#UEGWeekLive

[someuwin] 22/10/2019 08:27

Great news today.

Speedboat full commercial launch and number of products increased from 1 to 4.

[someuwin] 22/10/2019 07:11

22 October 2019

Creo Medical Group plc

("Creo" or the "Company")

Commercial Launch of Speedboat at UEG Week in Barcelona

Demonstration of wider suite of gastro-intestinal products awaiting regulatory clearance

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces the full commercial launch of its Speedboat device, the first in a range of gastrointestinal ('GI') devices to be cleared for use with the CROMA Advanced Energy platform which uniquely combines bipolar radiofrequency energy for precise tissue dissection along with microwave energy for highly controlled coagulation and tissue ablation.

Creo will be exhibiting at the United European Gastroenterology ('UEG') Week Congress in Barcelona from 21-23, October 2019 show-casing the CROMA Platform, powered by its unique full spectrum adaptive technology along with the GI suite of products for the dissection, resection, haemostasis and ablation of soft tissue. These products enable a wide variety of procedures, all of which are targeting treatment in the endoscopy room instead of the operating theatre wherever possible. This will be the first time the suite of products will have been fully demonstrated to the market as plans are put in place for first human cases.

Haemostasis device (HS1)* - is the ONLY non-stick haemostasis device in any sphere of therapy which builds on the excellent results seen clinically with the Speedboat device.

Resection device (RG1)* - is the ONLY bipolar RF scissors device in any sphere of therapy powered by the unique full spectrum adaptive technology in the CROMA platform. With capability to simultaneously utilise RF and Microwave energy this device truly brings laparoscopic surgical capability into the world of flexible endoscopic surgery.

Narrow Probe ablation needle (NP1)* - is the SMALLEST microwave ablation device in any sphere of therapy, providing precise and accurate delivery of microwave energy for ablation of soft tissue in various tissue types, ideal for the management of various GI disease states

*internal nomenclature

The commercial launch of the CROMA platform and Speedboat, along with the unveiling of a suite of devices at UEG Week is a major milestone for the Company and comes as a growing number of GI Endoscopists in the UK, mainland Europe, the US and South Africa have successfully completed training via the Clinical Education Programme and have now performed multiple successful procedures, removing lesions in both upper and lower GI cases using the device. The first commercial orders for Speedboat were announced in June this year.

UEG Week is a great opportunity for researchers and companies to present new research across a range of digestive disease areas and combines world class scientific research, invited lectures by leaders in gastroenterology and cutting-edge post-graduate teaching sessions to cover topics to interest the entire GI community.

The event is organised by the UEG Society and will take place at Fira Barcelona Gran Via, Barcelona, Catalonia, Spain. Creo Medical will be exhibiting at booth 46 throughout the event.

Craig Gulliford, Chief Executive Officer, commented:

"The full commercial launch of the Speedboat device, coupled with the opportunity to show-case the wider suite of products at this key event, is another important step for the Company. In addition to the profiling of our technology in the exhibition area, we will also be using the time together with our distribution partners throughout Europe to outline the initial roll out plans for the wider portfolio and use this fantastic opportunity to build further excitement and momentum as we head into 2020."

[someuwin] 12/10/2019 21:01

...Thanks for that.

Interesting that they say "Another four devices are being developed using the CROMA platform. These could be launched before the end of the year."

I didn't realise they were that close.

[dplewis1] 12/10/2019 09:37

CREO Medical best technology:https://www.ii.co.uk/analysis-commentary/best-aim-companies-2019-confirmed-ii509438

[dplewis1] 09/10/2019 11:16

Nice recovery going on here with some decent buying. One of those 'should have bought the dip' scenarios!

[someuwin] 26/9/2019 07:05

26 September 2019

Creo Medical Group plc

("Creo" or the "Company")

Framework Distribution Agreement for India

Indian doctors and nurses trained on Speedboat following signing

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces it has entered into a Distribution Partner Framework Agreement (the "Agreement") with MEDITEK SYSTEMS ("Meditek"), to provide clinical training and market seeding across the Indian market for Creo's CROMA Advance Energy platform and suite of products, including the Speedboat device, ahead of their official launch.

Meditek will collaborate with Creo to advance the roll out of Creo's Clinical Education Programme across the Indian market, training key clinicians in the use of Speedboat and the CROMA platform with the aim of ensuring quality control and best patient outcomes. Creo's Clinical Education Programme ensures that distributor trainers, having been carefully mentored, can then deliver in-country training for clinicians at a consistently high standard.

In addition, doctors and nurses from six key healthcare institutions in India have already completed training as part of Creo's Clinical Education Programme ahead of the mentoring phase of the programme with initial cases taking place in India over the coming weeks.

Meditek will continue to operate the Clinical Education Programme in India and will commence seeding these markets with Creo's products, with the ultimate objective of entering into a formal long-term distribution agreement once the seeding phase has completed. The Agreement requires Meditek to purchase a minimum quantity of CROMA advance energy platforms and Speedboat products during the initial period.

[dplewis1] 26/9/2019 07:03

Moving into India as well..excellent

[someuwin] 18/9/2019 13:01

Interim results due sometime in the next eight trading days.

[dplewis1] 18/9/2019 10:44

Gold sponsors are Pentax Medical. Surgeons from all over the world attending so good exposure for CREO's kit.

[someuwin] 18/9/2019 10:22

Creo Medical‏ @CreoMedical · 28 minutes ago

We’re delighted to be working with @tsiamoulos as Platinum Sponsors of the Kent #Endoscopy Course, featuring live cases by international experts from 17-19th October …

[someuwin] 16/9/2019 09:05

All buys so far today.

[someuwin] 13/9/2019 16:23

Cenkos - 10 September 2019

Creo Medical Group Plc

Clinician cascade

Creo Medical has announced the initiation of phase II of its clinical education programme for its lead product, Speedboat, in the US. This is a significant step, seeing a recently trained US gastrointestinal (GI) endoscopist training three further US clinicians. While Creo itself can train a number of physicians per year, having its trained practitioners running training programmes themselves will create a cascade effect, multiplying the number of trained Speedboat users, and therefore customers, working in the US. We maintain our Buy recommendation..."

[dplewis1] 13/9/2019 16:19

About bloody time ..this was well over 2 quid not long ago!

[someuwin] 13/9/2019 16:00

Buyers piling in today!

[charliekawai] 08/8/2019 15:29

Sadly short sighted. Creo has amazing technology and devices that meet key clinical needs, some of which aren’t currently being met. I really see this technology having the same impact the Harmonic Scalpel did on JNJ’s Ethicon business. Slow starter but now world class main stream advanced energy devices driving a multi billion dollar market.

[dplewis1] 31/7/2019 15:55

Somebody wants out of these badly, not cool.

[dplewis1] 26/7/2019 09:37

Tweet from CREO@CreoMedical We're all set for our first multi-centre mentoring session in Madrid today with our partners @HospitalariaJjp

[dplewis1] 25/6/2019 12:02

It's a proper outfit, make no mistake. I've been in since 70p and have no intention of selling. It requires patience, but has the potential to be a globally successful medical device player.

[lurki0] 25/6/2019 11:37

Sales in the US! That is quite a vote of confidence in the product and the company.

CREO is shaping up to be a very promising investment. No BS from the board, just the facts as and when necessary.

[dplewis1] 25/6/2019 07:08

Hopefully the news this morning will help to reverse the decline we've seen over the past couple of weeks..

[pecuniarum copia] 17/6/2019 09:24

This is Money (Mail on Sunday ~ Midas) link...